PTLA
Portola Pharmaceuticals, Inc.
PTLA
PTLA
Delisted
PTLA was delisted on the 1st of July, 2020.
201 hedge funds and large institutions have $1.92B invested in Portola Pharmaceuticals, Inc. in 2019 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 71 increasing their positions, 56 reducing their positions, and 36 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
23% less call options, than puts
Call options by funds: $22.2M | Put options by funds: $28.9M
25% less funds holding in top 10
Funds holding in top 10: 8 → 6 (-2)
Holders
201
Holding in Top 10
6
Calls
$22.2M
Puts
$28.9M
Top Buyers
| 1 | +$22.9M | |
| 2 | +$18.5M | |
| 3 | +$14.6M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$9.69M |
| 5 |
ACM
Asymmetry Capital Management
San Francisco,
California
|
+$9.27M |
Top Sellers
| 1 | -$90.8M | |
| 2 | -$14.7M | |
| 3 | -$13.2M | |
| 4 |
UBS AM
Chicago,
Illinois
|
-$7.23M |
| 5 |
MCM
Moore Capital Management
New York
|
-$5.22M |